Role of Dexmedetomidine as Synergistic Agent

Clinical trial NCT06662175 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06662175
Sponsor: Lady Reading Hospital, Pakistan
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Dexmedetomidine Hyperbaric Bupivacaine Subarachnoid Anesthesia

Start date: 2024-11-01
Primary completion: 2025-07-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.